Trial Profile
A Single-Centre, Retrospective Study Assessing the Safety and Efficacy of Ledipasvir and Sofosbuvir in Patients with Hepatitis-C Infection from a Federally Qualified Health Center [FQHC]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 19 Jul 2018 New trial record
- 05 Jun 2018 Results presented at the Digestive Disease Week 2018